Tactile Systems Technology, Inc. - Common Stock (TCMD)
Frequently Asked Questions About Tactile Systems Technology, Inc. - Common Stock (TCMD)
How does Tactile Systems Technology, Inc. contribute to patient care?
Tactile Systems Technology, Inc. contributes to patient care by developing innovative and effective therapeutic devices that enhance treatment outcomes for individuals with chronic conditions. Through ongoing research and collaboration with healthcare professionals, the company aims to provide solutions that improve patient comfort, reduce healthcare costs, and ultimately lead to better health management.
How does Tactile Systems Technology, Inc. ensure product quality?
Tactile Systems Technology, Inc. ensures product quality through rigorous research and development processes, adherence to regulatory standards, and ongoing collaboration with healthcare professionals. The company conducts extensive clinical testing and gathers user feedback to continuously improve their products, aiming to meet the highest standards of safety and efficacy in the medical technology industry.
How does Tactile Systems Technology, Inc. handle customer feedback?
Tactile Systems Technology, Inc. places a strong emphasis on customer feedback as a vital component of their product development and improvement processes. The company actively collects input from healthcare providers and patients to understand their experiences and needs, using this information to make necessary adjustments, enhance product design, and ensure that their solutions effectively meet user requirements.
How does Tactile Systems Technology, Inc. support healthcare professionals?
Tactile Systems Technology, Inc. supports healthcare professionals by providing comprehensive training, educational resources, and clinical guidance around their products. The company strives to foster partnerships with clinicians and healthcare organizations to ensure effective implementation of their devices, thus enhancing patient outcomes and empowering healthcare providers in their treatment approaches.
How has Tactile Systems Technology, Inc.'s stock performed historically?
Historically, Tactile Systems Technology, Inc.'s stock has experienced fluctuations in line with market trends, company performance, and developments within the medical technology sector. Investors often look at financial reports, growth metrics, and market conditions to gauge the company's trajectory, which is influenced by product success, innovation, and market demand for therapeutic solutions.
Is Tactile Systems Technology, Inc. publicly traded?
Yes, Tactile Systems Technology, Inc. is publicly traded on the NASDAQ stock exchange under the ticker symbol TCMD. As a publicly listed company, Tactile Systems is subject to regulatory requirements and reporting obligations associated with being a publicly traded entity, providing transparency to investors and stakeholders.
What are the key markets for Tactile Systems Technology, Inc.?
The key markets for Tactile Systems Technology, Inc. include the medical device and healthcare sectors, with a specific focus on products aimed at managing lymphedema, chronic venous insufficiency, and other related conditions. The company primarily serves healthcare providers and patients in the United States, but it also explores opportunities for international expansion to reach a broader audience.
What awards or recognitions has Tactile Systems Technology, Inc. received?
Tactile Systems Technology, Inc. has received several awards and recognitions for its innovations in the medical device field, especially related to its therapeutic products. These accolades highlight the company’s commitment to quality, patient satisfaction, and advancement in technology that effectively addresses the needs of patients with chronic conditions.
What does Tactile Systems Technology, Inc. do?
Tactile Systems Technology, Inc. is a medical technology company that develops and provides innovative products for people with chronic conditions. The company's primary focus is on providing therapeutic solutions to treat lymphedema, chronic venous insufficiency, and other related conditions. By utilizing advanced technology, Tactile Systems aims to improve the quality of life for patients by offering effective and user-friendly treatment options.
What is Tactile Systems Technology, Inc.'s mission?
The mission of Tactile Systems Technology, Inc. is to provide innovative medical solutions that improve the quality of life for patients with chronic conditions. By focusing on patient-centric design and clinical effectiveness, the company aims to empower individuals to take control of their health and navigate their recovery journeys with confidence.
What is the significance of the Flexitouch system?
The Flexitouch system is a flagship product of Tactile Systems Technology, Inc. that represents a significant advancement in the treatment of lymphedema and chronic venous insufficiency. This device utilizes pneumatic compression therapy to improve lymphatic function and enhance fluid drainage from affected areas, providing patients with a non-invasive, comfortable solution for managing their condition and improving their quality of life.
What is the vision of Tactile Systems Technology, Inc. for the future?
The vision of Tactile Systems Technology, Inc. for the future is to continue leading the way in medical technology innovation, with a strong emphasis on developing new therapeutic solutions that directly enhance patient care. The company aims to expand its product offerings, increase its market presence, and contribute significantly to the improvement of health outcomes for patients with chronic conditions worldwide.
What products does Tactile Systems Technology, Inc. offer?
Tactile Systems Technology, Inc. offers a range of medical devices designed to treat conditions such as lymphedema and chronic venous insufficiency. Their flagship products include the Flexitouch system, a pneumatic compression device that helps manage fluid buildup and improve circulation in affected patients, as well as other related therapeutic solutions aimed at enhancing patient comfort and recovery.
What recent developments has Tactile Systems Technology, Inc. made?
Recent developments at Tactile Systems Technology, Inc. include the expansion of their product line and enhancements in technology to improve the efficacy and usability of their devices. The company has also focused on increasing its market presence both domestically and internationally, as well as collaborations with healthcare practitioners to foster better treatment strategies and improve patient outcomes.
What role does research and development play at Tactile Systems Technology, Inc.?
Research and development play a critical role at Tactile Systems Technology, Inc. as the company continuously seeks to innovate and improve its product offerings. By prioritizing R&D, Tactile Systems can stay ahead of industry trends, address patient needs effectively, and enhance the clinical efficacy of their devices, ensuring that they remain competitive in the medical technology landscape.
When was Tactile Systems Technology, Inc. founded?
Tactile Systems Technology, Inc. was founded in 1995. The company has grown steadily since its inception, and through its commitment to innovation and quality, it has established itself as a leader in the medical technology sector, particularly in the realm of patient-focused care and therapeutic devices.
Where is Tactile Systems Technology, Inc. headquartered?
Tactile Systems Technology, Inc. is headquartered in Minneapolis, Minnesota. This location is strategic for the company as it allows them to stay close to a rich ecosystem of healthcare innovation and research, facilitating collaboration and development in the medical technology field.
Who are the primary customers of Tactile Systems Technology, Inc.?
The primary customers of Tactile Systems Technology, Inc. are healthcare providers, including hospitals, clinics, and medical professionals who treat patients with chronic conditions like lymphedema and chronic venous insufficiency. Additionally, the company markets its products directly to patients, offering home-based treatment solutions that empower individuals to manage their conditions effectively.
Who is the target audience for Tactile Systems Technology, Inc.'s products?
The target audience for Tactile Systems Technology, Inc.'s products includes patients suffering from chronic conditions like lymphedema and chronic venous insufficiency, as well as healthcare providers who administer treatments for these conditions. The company aims to serve both segments through education, support, and the provision of innovative medical devices tailored to their needs.
What is the current price of Tactile Systems Technology, Inc. - Common Stock?
The current price of Tactile Systems Technology, Inc. - Common Stock is 13.33
When was Tactile Systems Technology, Inc. - Common Stock last traded?
The last trade of Tactile Systems Technology, Inc. - Common Stock was at 4:00 pm EDT on April 7th, 2025
What is the market capitalization of Tactile Systems Technology, Inc. - Common Stock?
The market capitalization of Tactile Systems Technology, Inc. - Common Stock is 319.88M
How many shares of Tactile Systems Technology, Inc. - Common Stock are outstanding?
Tactile Systems Technology, Inc. - Common Stock has 24.00M shares outstanding.